The Life Sciences Industry Conference 2026 has announced its advisory committee, bringing together industry and academic leaders to help shape a programme focused on artificial intelligence and digital transformation across pharmaceutical manufacturing.

The conference, which takes place on Thursday, 22 October 2026, at the Crowne Plaza Hotel, Santry, Dublin, will examine how life sciences manufacturers can move beyond AI experimentation towards practical implementation at scale while maintaining regulatory compliance and operational performance.

Organised under the theme The AI Ready Manufacturing Site, the event will explore how enterprise AI, data analytics and digital innovation are changing manufacturing operations, with discussions centred on governance, validation, cybersecurity, workforce readiness and digital leadership.

The advisory committee includes Matt Moran, chief executive of Matt Moran Consulting and former leader of BioPharmaChem Ireland at Ibec, who brings more than three decades of experience supporting Ireland's pharmaceutical sector and now advises life sciences organisations on industry development.

Joining him is Dr Bernadette Whelan, Lecturer in Pharmaceutical Science and Programme Leader in GMP and Technology at South East Technological University Waterford, whose academic and industry experience spans pharmaceutical manufacturing, regulatory practice and competitive strategy.

The committee also includes Professor Radi Haloub, Professor of Interdisciplinary Health Education at University College London's Global Business School for Health, where he leads the Biotech and Pharmaceutical Management programme and contributes to leadership development across the healthcare and life sciences sectors.

Together, the committee will guide a conference programme designed to address the challenges manufacturers face as AI innovation becomes part of everyday operations rather than isolated pilot projects.

Four themed sessions will examine trust, governance and responsible AI, scaling AI from pilot to production, organisational change and workforce development, and the long term vision for the AI ready enterprise.

The discussions will consider how digital strategy, emerging technologies and business technology can support business transformation while preserving quality, compliance and patient safety in highly regulated manufacturing environments.

Visit the conference website and register your interest to be among the first to receive speaker announcements, programme updates and registration information.